Key result
Permanent pacing in long QT syndrome is linked to ~109-ms QT shortening and zero syncope recurrence.
Why the study?
Does permanent cardiac pacing combined with beta-blocker therapy reduce QT interval and prevent syncope or torsade de pointes in patients with long QT syndrome?
Observational (n=8)
Does permanent cardiac pacing combined with beta-blocker therapy reduce QT interval and prevent syncope or torsade de pointes in patients with long QT syndrome?
Permanent atrial or ventricular pacing (70-85 bpm) combined with beta-blocker therapy significantly shortens the QT interval and prevents syncope and torsade de pointes in high-risk long QT syndrome patients.
Answers are grounded in this paper and cite their sources.
Pacing may shorten QT and eliminate syncope in beta-blocked LQTS; hypothesis-generating without controls and should not yet change practice.
A permanent pacemaker was inserted in eight patients with the long QT syndrome. All had recurrent syncope or seizures, six had documented torsade de pointes and four had aborted sudden death. Among the eight patients, permanent pacing was instituted in three who were unsuccessfully treated with both a beta-adrenergic blocking agent and left cardiothoracic sympathectomy, and in two who proved refractory or intolerant to beta-blockers. Another three patients had pacemaker implantation and long-term beta-blocker therapy because of spontaneous atrioventricular (AV) block in one, aborted sudden death in one and patient preference in one. After pacing (70 to 85 beats/min), there was no significant change in the mean corrected QT interval, but the mean QT interval decreased significantly (534.4 +/- 51.4 to 425.6 +/- 18.9 ms, p less than 0.0001). Over a mean follow-up period of 35.1 +/- 18.9 months, all patients are alive and currently free of syncope. One patient without a history of stress-induced syncope had two syncopal episodes (believed to be due to hyperventilation) while under severe emotional stress, but has been symptom free for the past 5 years. One patient with an atrial demand (AAI) pacemaker developed dizziness due to documented episodes of AV block, but remains asymptomatic after conversion to atrial rate-responsive dual chamber (DDD) pacing. Either atrial or ventricular pacing combined with beta-blocker therapy appears to be effective treatment for a subset of patients with the long QT syndrome, by either preventing episodes of torsade de pointes or alleviating symptoms due to bradycardia from beta-blocker therapy.
No takes yet. Share an insight, caveat, or question.
Eldar et al. (1987) conducted an observational in Long QT syndrome (n=8). Permanent cardiac pacing (70 to 85 beats/min), often combined with beta-blocker therapy vs. Pre-pacing baseline was evaluated on Mean QT interval (ms) (p=<0.0001). Permanent cardiac pacing in 8 long QT syndrome patients shortened the mean QT interval, with 100% survival and current freedom from syncope over 35.1 months.
Synapse has enriched 10 related papers. Consider them for comparative context: